1. Home
  2. TCBK vs NTLA Comparison

TCBK vs NTLA Comparison

Compare TCBK & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCBK
  • NTLA
  • Stock Information
  • Founded
  • TCBK 1975
  • NTLA 2014
  • Country
  • TCBK United States
  • NTLA United States
  • Employees
  • TCBK N/A
  • NTLA N/A
  • Industry
  • TCBK Major Banks
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • TCBK Finance
  • NTLA Health Care
  • Exchange
  • TCBK Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • TCBK 1.4B
  • NTLA 1.2B
  • IPO Year
  • TCBK N/A
  • NTLA 2016
  • Fundamental
  • Price
  • TCBK $44.23
  • NTLA $12.62
  • Analyst Decision
  • TCBK Buy
  • NTLA Buy
  • Analyst Count
  • TCBK 5
  • NTLA 20
  • Target Price
  • TCBK $48.60
  • NTLA $25.48
  • AVG Volume (30 Days)
  • TCBK 101.0K
  • NTLA 10.5M
  • Earning Date
  • TCBK 10-23-2025
  • NTLA 11-06-2025
  • Dividend Yield
  • TCBK 3.26%
  • NTLA N/A
  • EPS Growth
  • TCBK 5.66
  • NTLA N/A
  • EPS
  • TCBK 3.55
  • NTLA N/A
  • Revenue
  • TCBK $399,268,000.00
  • NTLA $52,857,000.00
  • Revenue This Year
  • TCBK $9.45
  • NTLA $9.20
  • Revenue Next Year
  • TCBK $5.81
  • NTLA N/A
  • P/E Ratio
  • TCBK $12.46
  • NTLA N/A
  • Revenue Growth
  • TCBK 3.12
  • NTLA 14.99
  • 52 Week Low
  • TCBK $35.20
  • NTLA $5.90
  • 52 Week High
  • TCBK $51.06
  • NTLA $28.25
  • Technical
  • Relative Strength Index (RSI)
  • TCBK 55.63
  • NTLA 33.36
  • Support Level
  • TCBK $43.09
  • NTLA $11.63
  • Resistance Level
  • TCBK $44.66
  • NTLA $26.35
  • Average True Range (ATR)
  • TCBK 1.18
  • NTLA 1.86
  • MACD
  • TCBK 0.24
  • NTLA -1.93
  • Stochastic Oscillator
  • TCBK 89.81
  • NTLA 5.96

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: